Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Apr 25, 2024 |
| 8-k/a | 8K-related | 16 | Apr 24, 2024 |
| 4 | Insider transactions | 1 | Mar 19, 2024 |
| 3 | Insider transactions | 1 | Mar 13, 2024 |
| 8-k | 8K-related | 15 | Mar 13, 2024 |
| 4 | Insider transactions | 1 | Mar 13, 2024 |
| 8-k | 8K-related | 14 | Mar 07, 2024 |
| 8-k | 8K-related | 14 | Mar 05, 2024 |
| 4 | Insider transactions | 1 | Feb 28, 2024 |
| 3 | Insider transactions | 1 | Feb 23, 2024 |